---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-089164"
form_type: "8-K"
ticker: "HIT"
cik: "0002019505"
company_name: "Health In Tech, Inc."
filed_at: "2026-08-13T20:35:15+00:00"
generated_at: "2026-08-13T20:36:06.545032+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Health In Tech Q2 2026 revenue down 13% to $8.1M; net loss $2.5M vs prior-year income

## Summary
- Q2 2026 revenue $8.1M vs $9.3M in Q2 2025; net loss $2.5M ($0.04/share) vs net income $0.6M ($0.01/share).
- Adjusted EBITDA -$1.3M in Q2 2026; first-half 2026 revenue $16.8M vs $17.3M prior year.
- Contracted revenue $32.3M as of June 30, 2026; pipeline revenue $66.3M as of July 31, 2026.
- Distribution partners 933, up 19.9% YoY; reaffirms FY2026 revenue guidance of $45-50M.
- Secured first employer group for Three-Year Rate Stabilization Program; HitRix launch expected H2 2026.

## SEC filing metadata
- accession: 0001213900-26-089164
- form_type: 8-K
- ticker: HIT
- cik: 0002019505
- company_name: Health In Tech, Inc.
- filed_at: 2026-08-13T20:35:15+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2019505/000121390026089164/0001213900-26-089164-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2019505/000121390026089164/ea0301980-8k_health.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-089164
- JSON: https://secwatch.observer/filing/0001213900-26-089164.json
- Plain text: https://secwatch.observer/filing/0001213900-26-089164.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
